Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Certain dietary supplements can improve hair density and are well-tolerated for treating androgenetic alopecia.

Sex hormones affect liver fat and metabolic health differently in men and women.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Understanding hair health and disorders is important for effective treatment.

Higher testosterone and dehydroepiandrosterone sulphate levels may help diagnose meibomian gland dysfunction.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

The treatment effectively reduces menopausal symptoms and is well tolerated.

Spironolactone is effective for treating female hair loss, with new treatments like clascoterone showing promise.

The method accurately measures sex hormones in human plasma but can have small errors.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Finasteride helps reduce hidradenitis suppurativa symptoms in females.

High testosterone increases heart disease risk in women with PCOS.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Adaptive coping reduces PCOS symptoms, while maladaptive coping worsens them.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.